Sonosemi Medical Co., Ltd. (referred to as "SONOSEMI ") founded in April 2020 and headquartered in Shenzhen, China, is a National High-Tech Enterprise and a National-Level Specialized, Refined, Distinctive, and Innovative ("Little Giant") Enterprise. We are dedicated to technological innovation and commercialization in the field of vascular active interventional diagnosis and therapy.
As a leading provider and pioneer of domestic solutions in this sector, SONOSEMI consistently stays at the forefront of the industry, addressing unmet clinical needs. We are committed to delivering greener, more precise, and safer product solutions. Driven by a dual-engine model of "Clinical Needs + Technological Innovation," and powered by a pioneering spirit and strong R&D capabilities, the company adopts an integrated strategy of research, production, and sales alongside open collaboration. We have taken the lead in introducing innovative products such as the Coronary Intravascular Lithotripsy System, Peripheral Intravascular Lithotripsy System, Intracardiac Echocardiography (ICE) System, and Intravascular Ultrasound (IVUS) Diagnostic System. Through these efforts, we are progressively building a comprehensive vascular interventional diagnosis and therapy portfolio, striving to create greater value for physicians and patients alike.
